Altria Group, Inc.
Altria Reports Q2 2024 Financial Results and Narrows Guidance
Summary
Altria Group, Inc. reported financial results for Q2 2024, showing a net revenue decrease of 4.6% to $6.2 billion and adjusted diluted EPS unchanged at $1.31. The company also narrowed its 2024 full-year adjusted diluted EPS guidance to a range of $5.07 to $5.15. Key highlights include strong performance in smoke-free products and significant cash returns to shareholders through dividends and share repurchases.
Profitelligence Alerts
Get alerts for MO
Be first to know when Altria Group, Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Altria Group, Inc.
Altria Group, Inc. is a holding company with a primary focus on the manufacture and sale of cigarettes and related products. Serving as a leading player in the tobacco industry, Altria is best known for its premium cigarette brand, Marlboro, which holds a significant market share in the United States. Beyond cigarettes, the company has established a diversified portfolio by investing in smokeless tobacco products, wine via its subsidiary Ste. Michelle Wine Estates, and a stake in the cannabis market through its investment in Cronos Group. Altria's strategic expansions into non-cigarette categories reflect its aim to navigate changing consumer preferences and regulatory landscapes. As one of the foremost publicly traded entities in its sector, Altria plays a significant role in the broader consumer goods market. The company continues to engage with shifting market dynamics by fostering innovation in reduced-risk products while maintaining its strong presence in traditional tobacco markets.
Official SEC Documents
Advertisement